Emerging evidence suggests long-term use of hypnotics may be associated with increased risk of dementia and mortality
Chen P-L, Lee W-J, Sun W-Z, Oyang Y-J, Fuh J-L. Risk of dementia in patients with insomnia and long-term use of hypnotics: a population-based retrospective cohort study. PLoS ONE. (2012) 7:e49113. doi: 10.1371/journal.pone.0049113. PubMed Abstract | CrossRef Full Text | Google Scholar
de Gage SB, Bégaud B, Bazin F, Verdoux H, Dartigues J-F, Pérès K, et al. Benzodiazepine use and risk of dementia: prospective population based study. BMJ. (2012) 345:e6231. doi: 10.1136/bmj.e6231. PubMed Abstract | CrossRef Full Text | Google Scholar
Gallacher J, Elwood P, Pickering J, Bayer A, Fish M, Ben-Shlomo Y. Benzodiazepine use and risk of dementia: evidence from the Caerphilly Prospective Study (CaPS). J Epidemiol Community Health. (2012) 66:869–73. doi: 10.1136/jech-2011-200314. PubMed Abstract | CrossRef Full Text | Google Scholar
Chiu H-Y, Lin E-Y, Wei L, Lin J-H, Lee H-C, Fan Y-C, et al. Hypnotics use but not insomnia increased the risk of dementia in traumatic brain injury patients. Eur Neuropsychopharmacol. (2015) 25:2271–7. doi: 10.1016/j.euroneuro.2015.09.011. PubMed Abstract | CrossRef Full Text | Google Scholar
Jaussent I, Ancelin M-L, Berr C, Pérès K, Scali J, Besset A, et al. Hypnotics and mortality in an elderly general population: a 12-year prospective study. BMC Med. (2013) 11:212. doi: 10.1186/1741-7015-11-212. PubMed Abstract | CrossRef Full Text | Google Scholar
Kripke DF, Garfinkel L, Wingard DL, Klauber MR, Marler MR. Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry. (2002) 59:131–6. doi: 10.1001/archpsyc.59.2.131. PubMed Abstract | CrossRef Full Text | Google Scholar